On Wednesday, ValueTheMarkets’ Ben Turney hosted Maurice Treacy, director at rare disease and orphan drug-focused pharma services company Open Orphan, in a recorded presentation and interview....

On Wednesday, ValueTheMarkets’ Ben Turney hosted Maurice Treacy, director at rare disease and orphan drug-focused pharma services company Open Orphan, in a recorded presentation and interview....
Ophir Energy (LSE:OPHR) rose 2pc to 57.1p on Thursday morning after receiving an increased recommended final cash offer from Medco. Back in January, the business accepted Medco Energi Global’s...
Ophir Energy (LSE:OPHR) has received a firm cash offer of 55p per share from Medco Energi Global. The offer values the entire share capital at £390.6m and is an improvement on Medco’s rejected...
Ophir Energy (LSE:OPHR) sat flat at 44.9p on Monday morning after rejecting a take over offer from PT Medco Energi Global PTE Ltd. Ophir first confirmed it was in discussions with Medco on 1...
Ophir Energy (LSE:OPHR) shot up by nearly a third on Wednesday to 46.9p after revealing that it could be purchased by a leading Southeast Asian energy and natural resources company. In response to...
This morning, Ophir Energy (LSE:OPHR) released positive news on a number of fronts, namely an extension of its Reserve Based Lending Facility (RBL) and a reduction in previously forecast net debt...
Ophir Energy (LSE:OPHR) advanced 2pc to 33.8p this morning following a mixed update that saw it announce one gas discovery and one dry well across its assets in South East Asia. The business said...
Oil prices fell sharply yesterday to levels last seen seven months ago. WTI Crude futures dipped 2.5% while Brent futures lost 3.5% on the day. The general consensus is that a continued increase in...
Thanks to delays and write-downs related to its Fortuna development, shares in Ophir Energy (LSE:OPHR) have suffered this year, falling from highs of 76p in January to their current 42p. However,...